New York City-based Kadmon Corp., a biopharma focused on developing therapies for significant unmet medical needs, recently announced the start of the first dosing regimen in a patient in its Phase 2 clinical trial assessing the drug KD025, the company’s rho-associated coiled-coil kinase 2 (ROCK2) inhibitor, for the treatment of idiopathic pulmonary fibrosis…
Germany based Boehringer Ingelheim and France based Inventiva have announced a new multi-year research and drug discovery collaboration and licensing agreement. Under the agreement, Inventiva and Boehringer Ingelheim teams will work on validation of a new therapeutic concept to discover new medicines for treating idiopathic pulmonary fibrosis (IPF) and other…
A recent study from Korea indicates that sublobar resection is less likely to result in death compared to a lobar resection for lung cancer patients with idiopathic pulmonary fibrosis. The research report, “Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with…
Boehringer Ingelheim and Inventiva recently signed a new multi-year drug discovery and research partnership and licensing agreement. Research teams from both companies will jointly work to validate a new therapeutic concept with the purpose of finding novel therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. The…
There are many shared risk factors for the development of the lung diseases pulmonary fibrosis (PF) and chronic obstructive pulmonary disease (COPD), but researchers of the two chronic conditions usually focus on understanding each disease separately. New research has found evidence that there may be a common genetic predisposition for the development of…
1. Bill Bright William R. Bright, best known as Bill Bright, is the co-founder of the largest Christian ministry in the world, the Campus Crusade for Christ. In 2003, he died from complications related to pulmonary fibrosis, as announced on his website. 2. Boyd Bennett The…
In this video from schoolofmedicine, meet Hamish S. Osborne and Christine C. Osborne. Mr. Osborne was diagnosed with IPF and had go to through surgery for a double-lung transplant. After that procedure, the couple became parte of the founding supporters of the Program in Lung Healing.
PFF Care Center Network is a group of medical centers which dedicate their work to improving the lives of those living with pulmonary fibrosis. According to the Pulmonary Fibrosis Foundation, these kinds of centers are expanding and keep growing. Their main purpose is to treat patients with fibrotic lung…
Meet Larry Rawdon. He’s a two-time Mayo Clinic lung transplant recipient and in this video you can see him sharing the power of music in his harmonica class. In this video, shared by Mayo Clinic in 2013, Rawdon shares his passion for the harmonica and…
Having trouble breathing while you suffer from a pulmonary disease such as pulmonary fibrosis, is one of the most common and life-threatning symptoms. There are several treatments to help ease these symptoms, such as medication, oxygen therapy and pulmonary rehabilitation. Breathing exercises can be of an extreme help because…
Get regular updates to your inbox.
